Experimental tablet produces encouraging results in patients with world’s most common forms of disease

• ‘I was getting ready to say goodbye’: patient’s hope after smart drug success

A smart drug that stops cancer cells “hiding” from treatment can shrink tumours by at least 30% in six of the world’s most common forms of the disease, early trial results show.

While immunotherapy treatments have improved survival rates for many patients, their effectiveness can stall or fail when tumour cells hide and then spread.

Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes

• ‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy

Millions of women with breast cancer could be spared chemotherapy with a groundbreaking genomic test, according to the results of a trial that could transform healthcare guidelines worldwide.

Treatment for breast cancer, the world’s most prevalent form of the disease, involves surgery to remove tumours. Chemotherapy is then usually recommended when doctors believe there is a risk the disease will return.